The Monocyte/HDL Cholesterol Ratio in Obstructive Sleep Apnea Syndrome

Basit Öğe Kaydı
dc.authoridAcat, Murat/0000-0002-7163-4882
dc.contributor.authorAcat, Murat
dc.contributor.authorYazici, Onur
dc.date.accessioned2024-09-29T16:08:32Z
dc.date.available2024-09-29T16:08:32Z
dc.date.issued2019
dc.departmentKarabük Üniversitesien_US
dc.description.abstractObjective: Obstructive Sleep Apnea syndrome (OSAS) is the most common condition among sleep-related respiratory disorders. The etiology is not clear. However, systemic and local inflammation in the respiratory tract of the patients has been acknowledged. Monocytes and macrophages play the critical role in the inflammation process. These cells participate in the release of the proinflammatory cytokines in inflammation sites. High-density lipoprotein (HDL) cholesterol is a molecule with an anti-inflammatory effect. Monocyte/HDL cholesterol ratio (MHR) is an inflammation marker being used recently. In our study, we aimed to compare inflammation marker levels between patients diagnosed with OSAS with subsequent polysomnography and the non-OSAS group, determine the relationship between the severity of OSAS and MHR and, investigate the utility of the MHR for diagnosing OSAS. Materials and Methods: The data from the patients' files who had polysomnography due to OSAS symptoms in our unit between July 2017 and December 2017 have been retrospectively analyzed, and polysomnography results were recorded. Demographic data and the results of biochemistry and complete blood count panels of patients with OSAS and who were not also were recorded. Results: Out of 147 patients who underwent polysomnography in the period identified, 104 were diagnosed with OSAS. Monocyte count and MHR values were significantly high (p<0.0001 in both) and HDL levels were significantly low (p=0.03) in OSAS group. There was also a moderately significant positive correlation between apnea-hypopnea index (AHI) and MHR (p<0.0001, r=0.411). Conclusion: MHR may be a useful tool for diagnosing OSAS. Because of the positive correlation between MHR and AHI which represents the severity of the disease, MHR may be used for the classification of OSAS.en_US
dc.identifier.doi10.4274/meandros.galenos.2018.63935
dc.identifier.endpage208en_US
dc.identifier.issn2149-9063
dc.identifier.issue3en_US
dc.identifier.startpage204en_US
dc.identifier.trdizinid363561en_US
dc.identifier.urihttps://doi.org/10.4274/meandros.galenos.2018.63935
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/363561
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7606
dc.identifier.volume20en_US
dc.identifier.wosWOS:000531091400003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofMeandros Medical and Dental Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectObstructive Sleep Apnea syndromeen_US
dc.subjectmonocyteen_US
dc.subjectHDLen_US
dc.subjectcholesterolen_US
dc.subjectpolysomnographyen_US
dc.titleThe Monocyte/HDL Cholesterol Ratio in Obstructive Sleep Apnea Syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu